Aquestive therapeutics, inc. (AQST)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
Assets
Current assets:
Cash and cash equivalents

35,521

49,326

20,914

22,165

39,934

60,599

63,982

10,638

17,379

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).

9,536

13,130

10,316

10,150

7,489

6,481

-

-

6,179

Accounts receivable, net

-

-

-

-

-

-

7,450

6,629

-

Inventories, net

3,087

2,859

4,124

4,647

5,137

5,441

4,483

4,348

4,014

Prepaid expenses and other current assets

2,944

2,999

2,706

2,102

3,398

1,680

1,444

5,034

591

Total current assets

51,088

68,314

38,060

39,064

55,958

74,201

77,359

26,649

28,163

Property and equipment, net

9,059

9,726

10,351

10,933

11,594

12,207

12,211

12,766

13,460

Right-of-use assets, net

3,912

0

-

-

-

-

-

-

-

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life and amount of noncurrent assets classified as other..

428

439

-

-

-

443

-

-

-

Intangible assets, net

-

-

165

178

191

-

216

229

254

Other assets

-

-

242

233

236

-

224

197

1,239

Total assets

64,487

78,479

48,818

50,408

67,979

86,851

90,010

39,841

43,116

Liabilities and stockholders' deficit
Current liabilities:
Accounts payable

-

-

-

-

-

20,436

-

-

9,601

Accrued expenses

-

-

-

-

-

7,195

-

-

4,402

Accounts payable and accrued expenses

14,090

17,749

19,218

23,479

22,088

-

17,798

21,140

-

Lease liabilities, current

609

0

-

-

-

-

-

-

-

Deferred revenue, current

663

806

835

600

700

721

-

-

-

Deferred revenue

-

-

-

-

-

-

781

1,234

1,347

Loans payable, current

-

-

0

550

6,850

4,600

2,750

1,100

0

Total current liabilities

15,362

18,555

20,053

24,629

29,638

32,952

21,329

23,474

15,350

Loans payable, net

60,922

60,338

59,775

46,884

40,742

42,603

44,054

45,330

45,507

Lease liabilities

3,424

0

-

-

-

-

-

-

-

Deferred revenue, net of current portion

4,209

4,348

2,127

2,266

2,405

0

-

-

-

Warrant liability

-

-

-

-

-

-

0

8,835

7,673

Asset retirement obligations

1,399

1,360

1,322

1,286

1,250

1,216

1,183

1,150

1,081

Total liabilities

85,316

84,601

83,277

75,065

74,035

76,771

66,566

78,789

69,611

Contingencies (note 18)

-

-

-

-

-

-

0

0

-

Stockholders' deficit:
Common interests, no par value. Authorized 500,000,000 units; 121,228,353 units issued and outstanding at December 31, 2017

-

-

-

-

-

-

0

0

12,727

Common stock, $.001 par value. Authorized 250,000,000 shares; 33,582,696 and 33,562,885 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

34

34

25

25

25

25

25

20

0

Additional paid-in capital

126,141

124,318

83,354

74,744

72,873

71,431

70,851

-6,574

0

Accumulated deficit

-147,004

-130,474

-117,838

-99,426

-78,954

-61,376

-47,432

-32,394

-120,093

Total stockholders' deficit

-20,829

-6,122

-34,459

-24,657

-6,056

10,080

23,444

-38,948

-68,596

Total liabilities and stockholders' deficit

64,487

78,479

48,818

50,408

67,979

86,851

90,010

39,841

43,116

Outstanding nonredeemable series A-3 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for redeemable preferred interest and accrued dividends.

-

-

-

-

-

-

-

-

5,896

Outstanding nonredeemable series A-2 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for redeemable preferred interest and accrued dividends.

-

-

-

-

-

-

-

-

36,205

Series A Preferred Stock [Member]
Preferred interests

-

-

-

-

-

-

-

-

16,887

Total shareholders equity/members (deficit)

-

-

-

-

-

-

-

-

16,887

Outstanding nonredeemable series A-1 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.
Preferred interests

-

-

-

-

-

-

-

-

21,883

Total shareholders equity/members (deficit)

-

-

-

-

-

-

-

-

21,883